BeOne Medicines
Megan D'Andreti is a seasoned professional in clinical operations, currently serving as a Global Clinical Study Senior Manager in the Biotech Unit at BeiGene since October 2019. Prior experience includes roles at Amgen FSP as a Clinical Trial Manager, and a progression through various positions at Parexel, Sanofi, and Smith & Nephew, where responsibilities encompassed clinical research and management. Educational qualifications include a Bachelor's degree in Biotechnology from Western Sydney University and ongoing Master's degree studies at Macquarie University, complemented by a Mandarin language certification.
This person is not in any teams
This person is not in any offices
BeOne Medicines
34 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.